NEW YORK, March 12 – Three Bruker companies, Bruker Daltonics, Bruker AXS, and Bruker Instruments have agreed to work with Integrative Proteomics (IPI) to develop a high-throughput platform for protein identification and characterization, the companies said Monday.

IPI, based in Toronto, will purchase x-ray crystallography, high-field NMR, and MALDI-TOF mass spectrometry systems from Bruker. In addition, the Bruker companies will make an undisclosed equity contribution in IPI.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.